Human T-cell lymphotropic virus type I (HTLV-I) is associated with various clinical disorders including adult T cell leukemia, myelopathy, arthropathy. Hypercalcemia resulting from osteoclast activation and a variety of hematopoietic abnormalities have been also observed in HTLV-I infected patients, however, precise mechanism about initial trigger(s) prior to presenting symptoms is still unknown. In this study, to assess eects of HTLV-I on hematopoiesis, we analysed characteristics of early hematopoietic precursors in HTLV-I env-pX transgenic rats. Progenitor cells for osteoclasts were signi®cantly increased even in the marrow of asymptomatic env-pX rats. Progenitors for B cells were also highly enriched, while colony forming cells (CFC) elicited by GM-CSF(CFU-GM) and M-CSF(CFU-M) were comparable to normal littermates. Following arthritis in env-pX transgenic rats, osteoclastogenesis was further augmented and the CFCs were increased. Bone marrow cells carrying adjuvant-induced arthritis retained a constant number of progenitors for osteoclast and B lymphocytes, whereas the number of CFU-GM and CFU-M increased. These results indicate that the env-pX transgene aect early stages of osteoclast and B-cell lineages prior to developing diseases, in contrast, an increase of the CFCs was caused indirectly by arthritis. This study provides a novel standpoint for the mechanisms of pathogenesis by HTLV-I.
Introduction
Human T-cell lymphotropic virus type I (HTLV-I) is associated with various clinical disorders, including adult T cell leukemia (ATL), myelopathy/tropical spastic paraparesis (HAM/TSP), arthropathy (HAAP), uveitis (HU), Sjgren's syndrome, T cell alveolitis, polymyositis and dermatitis (Poiesz et al., 1980; Hollesberg and Ha¯er, 1993; Uchiyama, 1997) . In addition to T cell malignancies, HTLV-I shows pleiotropic eects on hematopoietic cells (Dean et al., 1987; Duggan et al., 1988; Tobinai et al., 1991; Hollesberg and Ha¯er, 1993; Cardoso et al., 1996) . Infection of HTLV-I has been shown to activate osteoclasts and induce hypercalcemia in large numbers of ATL patients (Kiyokawa et al., 1986) . Overproduction of the parathyroid hormone related protein (PTHrP) by ATL cells has been proposed to trigger hypercalcemia (Watanabe et al., 1990) . Granulocytosis and monocytosis are also known to follow HTLV-I infection (Nimer et al., 1989; Tokioka et al., 1994) . Although there is no evidence that HTLV-I infection directly leads B lymphomas (Dean et al., 1987; Duggan et al., 1988) , a few reports addressed HTLV-I infection results in activation of B lymphopoiesis (Tobinai et al., 1991; Cardoso et al., 1996) .
In the animal models, HTLV-I-tax transgenic mice (Nerenberg et al., 1987; Green et al., 1989; Iwakura et al., 1991; Ruddle et al., 1993) developed lymphoadenopathy and splenomegaly composed of B lymphocytes (Peebles et al., 1995) . Tax, a 40 kD nuclear protein encoded in the pX region of HTLV-I genome is known as transcriptional activator of viral genes and a number of cellular genes (Sodroski et al., 1984) . On the other hand, envelop glycoprotein of xenotropic murine leukemia virus, gp70 is related with several diseases and development of immune complexes in lupus nephritis of New Zealand mice (Yoshiki et al., 1974) . A human endogenous retroviral superantigen encoded by the envelop (env) gene is a candidate of autoimmune target in type I diabetes (Conrad et al., 1997) . Therefore, in addition to tax gene, HTLV-I-env gene may also play a role in the pathogenesis.
In our previous studies, to assess virus-host interactions and pathogenetic mechanisms in the diverse disorders observed in patients with HTLV-I, we have established HTLV-I carrier Wistar ± King ± Aptekman ± Hokudai (WKAH) rats which developed HAM/TSP-like myelopathy (Ishiguro et al., 1992) . We have also established the rats harboring the HTLV-IpX gene under the control of mouse H-2K d promoter developed mammary carcinomas (Yamada et al., 1995) . Our recent established transgenic rats carrying env-pX gene of HTLV-I controlled by own viral promoter exhibited collagen vascular diseases as rheumatoid-like arthropathy and produced autoantibodies, e.g. the rheumatoid factor, anti-dsDNA antibodies and cardiolipin . Although there is no report of animal model for T cell leukemia, env-pX transgenic rats are postulated as a comparable model for studying human diseases.
In this study, we focused on hematopoiesis of the env-pX transgenic rats and showed that progenitors for osteoclasts and B lymphocytes in the bone marrow were signi®cantly increased even in asymptomatic envpX rats prior to development of arthritis. Subsequently following arthritis, osteoclastogenesis was further augmented and increased numbers of granulocyte and monocyte progenitors elicited by GM ± CSF and M-CSF was observed. Adjuvant-arthritis in non-transgenic rats increased frequencies of granulocyte and monocyte progenitors, but did not change those of the progenitors for osteoclast and B lymphocytes. These results suggested that abnormalities of early hematopoiesis in osteoclast and B cell lineages might be resulted by an eect of env-pX transgene by itself rather than that of HTLV-I induced diseases.
Results
The frequency of osteoclast progenitors increased in env-pX transgenic bone marrow
It is known that the number of mature osteoclasts are increased in ATL patients (Kiyokawa et al., 1986) . To test whether the progenitors for osteoclast are increased in env-pX rats, we performed bone marrow cultures on the mouse stromal cell line ST2 which support hematopoiesis in the presence of DEX and 1a, 25-(OH) 2 D 3 . On the 6th day of culture, osteoclasts were detected by TRAP-staining. Fully functional multinuclear TRAP + cells capable to form pits on dentine slice were also detected in the culture. As shown in Figure 1a the numbers of both TRAP + -mononuclear cells and TRAP + -MNCs derived from the env-pX marrow (bars shown by Tg7) were three times higher than those of the normal littermates (bars shown by +/+). Similar results were obtained when we used bone marrow cells passed through a Sephadex G-10 column to deplete adherent stromal cells that might aect osteoclastogenesis (data not shown). Next, we assessed the frequency of osteoclast progenitors in the bone marrow of env-pX rats by using a limiting dilution assay. In this assay, serial numbers of bone marrow cells were cultured with ST2 in the presence of DEX and 1a, 25-(OH) 2 D 3 and the frequency of osteoclast progenitors were determined. As shown in Figure 1b , threefold more osteoclast progenitors were detected in env-pX rats (compare the bars in the graph indicated by Tg7 and +/+). The total cell number in the env-pX marrow did not signi®cantly change, i.e., 92.6+28.9 ( 610 76 ) and 116.0+61.5 (610
76
) per femur of normal littermates and env-pX transgenics, respectively. The env-pX transgenic rats used for the experiment in Figure 1 were inspected carefully for lack of symptoms of arthritis. These results indicate that env-pX transgene is responsible for the selective proliferation of osteoclast progenitors, even in the asymptomatic transgenic rats.
The frequency of B cell progenitors increased in env-pX transgenic bone marrow Although HTLV-I infection has been reported to induce pleiotrophic eects on hematopoietic cell lineages, it is not clear whether the increment of precursors is a speci®c characteristics of osteoclast lineage in the env-pX rat. To assess progenitors for monocyte and myeloid lineages, we analysed colony forming cells elicited by M-CSF (CFU-M) and GM ± CSF (CFU ± GM). In env-pX bone marrow, the numbers of CFU ± M and CFU ± GM did not change with those of normal controls ( Figure 2 Tg7 and +/ +). Next, to test B cell lineage, we determined the frequency of B cell progenitors by the limiting dilution assay. Serial numbers of bone marrow cells were cultured on ST2 in 96-well plates in the presence of mouse rIL-7 for 7 days and wells containing B lineage cells were counted. Surprisingly in env-pX rats, there were 3700 B cell progenitors per 10 6 bone marrow cells and the frequency was 5 ± 10-fold higher than that of normal littermates (Figure 3 Tg7 and+/+). Similar results were obtained when we used bone marrow cells passed through a Sephadex G-10 column to deplete adherent stromal cells that might aect B lymphopoiesis (data not shown). These observations indicate the eect of the env-pX transgene upon the growth of relatively early stage of osteoclast and B lineage cells, whereas the env-pX gene is less eective in promoting the growth of other progenitors responding to hematopoietic growth factors such as M-CSF or GM ± CSF.
env-pX transgenic rats developing arthritis showed augmented osteoclastogenesis
Results shown in the previous sections were obtained by using asymptomatic env-pX transgenic rats. Our established env-pX rats spontaneously developed arthritis at a 50% of ratio within 6 months after birth. We compared hematopoiesis in the transgenic rats with or without macroscopic arthritis. Both the generations of TRAP + cells in cultures and the frequency of their progenitors were signi®cantly enhanced in bone marrow cells of the env-pX transgenic rats with arthritis (compare Tg7 and Tg+ of Figure 1a and Figure 1b . The number of CFU ± M and CFU ± GM were also increased when they developed arthritis (Tg7 and Tg+ of Figure 2 ), whereas we could not detect B cell lineages in culture (Tg+ of Figure 3 ). Increased of CFU ± M and CFU ± GM might interfere the maintenance of B cell progenitors in bone marrow.
Induction of arthritis by adjuvant injection had no eect on the frequencies of progenitors for osteoclasts and B lymphocytes
To examine whether abnormal hematopoiesis in env-pX rats is the direct eect of the transgene or secondary eect by arthritis, we made another model carrying arthritis and analysed its eect on hematopoiesis. Lewis rats were treated with 0.1 ml Freund complete adjuvant subcutaneously to induce arthritis. After 3 weeks, colony forming cells in bone marrow by M ± CSF and GM ± CSF were 2 ± 3 times higher in arthritic rats than untreated rats (compare +/+ and +1, +2 of Figure 4c ). In contrast, the frequency of osteoclast progenitors was comparable to the normal controls (Figure 4b) , and osteoclasts generated in vitro were slightly increased (Figure 4a ). The frequency of B cell progenitors did not show any signi®cant dierence with that of the controls (Figure 4d ). These results demonstrated that the eects of adjuvant arthritis are restricted to granulocyte and monocyte lineages. In other words, arthritis does not necessarily increase the frequency of osteoclast and B cell progenitors. Instead, the increase of osteoclast and B cell progenitors is a speci®c event observed in the env-pX transgenic rats prior to the development of arthritis, indicating env-pX gene as the direct causative agent. Collectively, osteoclast progenitors were ®rst induced by the envpX gene, then following arthritis may act to induce further increase of these progenitors.
Discussion
Although animal model for ATL is not available so far, our established HTLV-I env-pX transgenic rats spontaneously develop collagen vascular diseases such as rheumatoid-like arthropathy and highly produce autoantibodies including the rheumatoid factor and directed to dsDNA , therefore useful as a comparable models for elucidating the pathogenesis of HTLV-I.
In the ATL patients, increase of osteoclasts in bone trabeculae has been reported (Kiyokawa et al., 1986) . In env-pX rats, the severe morphological change in Figure 3 The frequency of B cell progenitors in the env-pX transgenic bone marrow. A serial numbers of bone marrow cells (50, 100, 200, 400 cells/well) from normal littermates (+/+) and env-pX transgenic rats with (Tg+) or without (Tg7) macroscopic arthritis were cultured on ST2 stromal cells in the presence of mouse rIL-7 for 6 days in 96 well plates. The number of B cell progenitor-positive wells were counted. Data were selected from the plates containing an appropriate number of B cell progenitorpositive wells. Similar results were obtained from six independent experiments bone trabeculae has not been seen macroscopically and microscopically, except in articular osteocartilaginous region. Overproduction of PTHrP in patients has also been reported (Honda et al., 1988; Watanabe et al., 1990) . Considering the fact that PTHrP plays a critical role in osteoclastogenesis and is known to aect osteoclast dierentiation rather than osteoclast proliferation at relatively late stages (Suda et al., 1995) , the increased number of osteoclasts needs to be accounted for mechanisms other than PTHrP overproduction. To answer this question, we focused on the progenitor cells for osteoclasts in the env-pX transgenic rats. By using the mouse stromal cell line for feeder cells, we assessed osteoclast development from the bone marrow of env-pX transgenic rats. Osteoclast progenitors detected in our frequency analysis were immature and expressing the c-Kit receptor protein thyrosine kinase and not expressing the c-Fms (Hayashi et al., 1997) , a marker for more matured osteoclast progenitors which can respond to PTHrP stimulation (Tanaka et al., 1992) . The results showed that both mature osteoclasts and their progenitors were increased even in asymptomatic env-pX rats prior to development of arthritis. In contrast, enhancement of osteoclastogenesis was not observed in the rats carrying adjuvant arthritis. Based on these results, we have concluded that env-pX gene promotes to increase the number of osteoclast progenitors. It is not clear whether env-pX products aect on hematopoietic cells or microenvironments for hematopoiesis. Establishment of stromal cells which support hematopoiesis from the env-pX transgenic rats might be necessary to solve this problem. Production of many cytokines such as IL-1a, IL-6 and TNF-a was observed in various arthritis models (Feldman et al., 1996) although these cytokines are known to activate the function of mature osteoclasts (Gowen et al., 1983; Thomas et al., 1987; Suda et al., 1995) .
While HTLV-I infection leads to granulocytosis and monocytosis, monocytosis are also observed in patients with rheumatoid arthritis and animal models of arthritis induced by collagen and adjuvant injection (Hayashida et al., 1992; Hamilton, 1993) . In our experiments presented in Figure 2 spontaneous arthritis developed in env-pX transgenic rats enhances the number of granulocyte/monocyte colony forming cells. It should be emphasized that the increase of these colony forming cells were also observed in rats with adjuvant induced arthritis. Therefore, activation of granulocyte/monocyte lineages might be common phenomenon followed by arthritis rather than induced by env-pX transgene.
Following arthritis, elevation of cytokines production, e.g. TNFa, IL-1, IL-6, TGFb and GM ± CSF has been reported (Tendler et al., 1991; Tao et al., 1993) and this might be the possible explanation for the common phenomenon.
We observed increase of B cell progenitors in asymptomatic env-pX rats. Although there is no report that HTLV-I causes B cell lymphoma directly (Dean et al., 1987; Duggan et al., 1988) , a few reports addressed HTLV-I infection results in activation of B lymphopoiesis (Cardoso et al., 1996) . Tobinai et al. (1991) demonstrated that Epstein ± Barr virus genome carrying monoclonal B-cell lymphoma in an ATL-patient. Mice carrying HTLV-I-tax transgene developed lymphoadenopathy and splenomegaly composed of B lymphocytes, and some of cell lines established from these mice stimulated proliferation and dierentiation of normal splenic B cells (Peebles et al., 1995) . Our ®nding that envpX gene induced proliferation of immature B progenitors in bone marrow suggest that env-pX gene might play a role of lymphoproliferative disorders. Interestingly, B progenitors increased in asymptomatic env-pX transgenic bone marrow were disappeared after development of arthritis (Tg+ of Figure 3) . Overgrowth of macrophages and monocytes may had prevented B lymphopoiesis in vitro, since threefold numbers of granulocyte and monocyte precursors were observed in env-pX marrows with arthritis than in asymptomatic ones. Similar supression of B lymphopoiesis was observed in the long term bone marrow culture of mice defective SHP-1 protein tyrosine phosphatase, that causes massive growth of macrophages and granulocytes . Further examination to clarify the relationship between HTLV-I infection and B lymphopoiesis is needed.
Since the env-pX gene aected the relatively early stages of two distinct cell lineages, it is possible that this gene may also aect early stages such as hematopoietic stem cells. To test this possibility, we had tried to establish the conditions for forming colonies derived from hematopoietic stem cells in the spleen (CFU-S) whereas no CFU-S were generated so far in the rat system (Till and McCulloch, 1961) . Therefore, the eect of env-pX on the development of hematopoietic stem cells awaits further experimental progress.
In summary, we divided the progression of hematopoietic disorders into two phases in env-pX transgenic rats. First, in the bone marrow of asymptomatic env-pX rats without arthritis, progenitor cells for osteoclast and B cell increased. Following arthritis development, osteoclastogenesis is further augmented and colony forming cells elicited by GM ± CSF and M-CSF began to proliferate. The latter phase might be subjected to the indirect eect of the disease and may not be related with the env-pX gene itself.
Materials and Methods

Rats
Wistar ± King ± Aptekman ± Hokudai (WKAH) and Lewis rats were originally purchased from SLC Japan (Shizuoka, Japan) and maintained in the Laboratory Animal Research Center, Faculty of Medicine, Tottori University. WKAH rats carrying the HTLV-I env-pX transgene (env-pX) were used at 8 ± 10 weeks of age. The env-pX rats spontaneously develop collagen vascular diseases and macroscopic arthritis at approximately a 50% ratio by the time they reach 6-months old. The criteria for macroscopic arthritis is being a redness and swelling of joints macroscopically.
Induction of adjuvant arthritis
Adjuvant arthritis was induced in 8-week old male Lewis rats by a subcutaneous injection of 0.1 ml incomplete Freund adjuvant (Difco, Detroit, MI) containing 5 mg/ml heat-killed Mycobacterium tuberculosis H37RA (Difco) in the right foot (Taurog et al., 1985) . After 3 weeks of the injection, bone marrow cells from the left femora of the rats which developed polyarthritis were used for assays.
Cultures for osteoclasts
The mouse stromal cell line ST2 was plated into 24-well plates (#3047: Falcon Labware, Oxnard, CA) to prepare monolayers one day before bone marrow cells were added (Nishikawa et al., 1988 Cultures were fed on the third day by replacing 1 ml of fresh medium. Six days after the initiation of cultures, cells were ®xed and stained for tartrate resistant acid phosphatase (TRAP) (Shevde et al., 1994) . The number of TRAP-positive mononuclear cells and multinuclear cells (MNC) were represented as the mean+standard deviation (s.d.) of the triplicate cultures.
Frequency of osteoclast progenitors
The frequency of clonogenic osteoclast progenitors that proliferated and dierentiated on the ST2 stromal cell layer was determined by a modi®ed limiting dilution assay as described (Hayashi et al., 1990) . Brie¯y, 500 and 1000 cells diluted in 200 ml of medium containing DEX and 1a, 25-(OH) 2 D 3 were cultured with ST2 in 96-well plates (Falcon). Medium changes were carried out on the third day and on the sixth day, the cells were stained for TRAP. The well containing TRAP + -cell was recognized as the osteoclast progenitor positive well.
Frequency of B cell progenitors
Bone marrow cells (50, 100, 200 and 400 cells) were cultured on ST2 in RPMI-1640 (Gibco ± BRL) containing 5% CS, 5610
75 M 2-mercaptoethanol (2-ME: Wako Pure Chemical Industries, Ltd., Osaka, Japan) and 100 U/ml of mouse recombinant interleukin-7 (rIL-7). Three days after, 50 ml medium with 200 U/ml of mouse rIL-7 were added to each well. After 7 days, the number of B cell progenitor positive wells were counted under the microscope. Then, cells in the positive wells were collected, cytospun and stained with May ± GruÈ nwalds ± Giemsas solution and the presence of B cell progenitors was ascertained. In some experiments, cells were con®rmed by the staining of B lineage markers on¯ow cytometry.
TRAP staining for detection of osteoclasts
Cultured cells were ®xed with 10% of formalin (Wako) for 10 min and then with ethanol-aceton (50 : 50 v/v) (Wako) for 1 min at room temperature and incubated for 10 min in the TRAP staining buer (Shevde et al., 1994) .
In vitro colony formation
Bone marrow cells (2610 4 ) were cultured in 1 ml of a-MEM medium containing 1.2% methylcellulose (Muromachi Kagaku Kogyo, Tokyo, Japan), 30% fetal calf serum (Whittaker Bioproducts, Walkersviile, MD), 1% deionized bovine serum albumin (Sigma), 50 mM 2-ME, antibiotics, 5 ng/ml human rM-CSF and 100 U/ml mouse rGM-CSF. The number of colonies formed was counted on the 7th day after the inoculation (Hayashi et al., 1990; Metcalf et al., 1995) .
Statistical analysis
Data were presented as mean+s.d. Statistical signi®cance was estimated by Student's t-test.
Abbreviations HTLV-I, Human T-cell lymphotropic virus type I; ATL, adult T-cell leukemia; CFC, colony forming cells; CFU, colony forming unit; GM-CSF, granulocyte/macrophagecolony stimulating factor; M-CSF, macrophage-colony stimulating factor; PTHrP, parathyroid hormone related protein; 1a, 25-(OH) 2 D 3 ; 1a, 25-dihydroxyvitamin D 3 ; DEX, dexamethasone; TRAP, tartrate resistant acid phosphatase; IL-7, interleukin-7; TNFa, tumor necrosis factor.
